Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure
达格列净可减轻未患心力衰竭的 2 型糖尿病患者的全身炎症
期刊:
影响因子:
doi:10.21203/rs.3.rs-4132581/v1
Dennis Wang, Anna Naumova, Daniel Isquith, Jaime Sapp, Kim Anh Huynh, Isabella Tucker, Niranjan Balu, Anna Voronyuk, Baocheng Chu, Karen Ordovas, Charles Maynard, Rong Tian, Xue-Qiao Zhao, Francis Kim
代谢
心力衰竭
糖尿病
Immunology/Inflammation
IL-6
